Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiologie und Ursachen der Parkinson-Erkrankung
Christina M. Lill, Christine Klein
Der Nervenarzt (2017) Vol. 88, Iss. 4, pp. 345-355
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Could Alzheimer’s Disease Originate in the Periphery and If So How So?
Gerwyn Morris, Michael Berk, Michaël Maes, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 1, pp. 406-434
Open Access | Times Cited: 80
PINK1 Protects Auditory Hair Cells and Spiral Ganglion Neurons from Cisplatin-induced Ototoxicity via Inducing Autophagy and Inhibiting JNK Signaling Pathway
Qianqian Yang, Gaoying Sun, Haiyan Yin, et al.
Free Radical Biology and Medicine (2018) Vol. 120, pp. 342-355
Closed Access | Times Cited: 61
Non-polyphenolic natural inhibitors of amyloid aggregation
Liang Ma, Chen Yang, Jiaojiao Zheng, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112197-112197
Closed Access | Times Cited: 53
Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer’s disease, Parkinson’s disease, Huntington’s disease
Patcharapong Pantiya, Chanisa Thonusin, Nipon Chattipakorn, et al.
Mitochondrion (2020) Vol. 55, pp. 14-47
Closed Access | Times Cited: 51
Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke
Sejal Sharma, Saeideh Nozohouri, Bhuvaneshwar Vaidya, et al.
Life Sciences (2021) Vol. 274, pp. 119343-119343
Open Access | Times Cited: 49
Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review
A. Rodger, Maryam N. ALNasser, Wayne G. Carter
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11022-11022
Open Access | Times Cited: 20
Natural product-based pharmacological studies for neurological disorders
Vivek Puri, Neha Kanojia, Ameya Sharma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson’s disease
Qing Li, Chenye Shen, Zhaolin Liu, et al.
Cell Proliferation (2021) Vol. 54, Iss. 8
Open Access | Times Cited: 29
Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson’s Disease
Shakila Yaribash, Keyhan Mohammadi, Mahmood Alizadeh Sani
Cellular and Molecular Neurobiology (2025) Vol. 45, Iss. 1
Open Access
Risk of Parkinson’s Disease after a Diagnosis of Bacterial Pneumonia: A Nationwide Longitudinal Follow-up Study
Chih‐Sung Liang, Fu‐Chi Yang, Shih‐Jen Tsai, et al.
Journal of Medical Sciences (2025)
Open Access
Multi-omics data tools and integration approaches
Abdul Basit Ahanger, Syed Wajid Aalam, Ab Naffi Ahanger, et al.
Elsevier eBooks (2025), pp. 13-47
Closed Access
Morinda officinalis polysaccharide exerts anti-Parkinson’s disease effect via inhibiting NLRP3 inflammasome and improving pyroptosis of dopaminergic neurons
Yanhong Dong, F Wang, Mingji Jin
Molecular & Cellular Toxicology (2025)
Closed Access
Voice quality severity and responsiveness to levodopa in Parkinson’s disease
Daryn Cushnie-Sparrow, Scott Adams, Anita Abeyesekera, et al.
Journal of Communication Disorders (2018) Vol. 76, pp. 1-10
Closed Access | Times Cited: 28
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Literature Review of Pre-Clinical Studies
Samay Prakash, Wayne G. Carter
Brain Sciences (2021) Vol. 11, Iss. 12, pp. 1573-1573
Open Access | Times Cited: 23
Parkinson’s Disease: A Nanotheranostic Approach Targeting Alpha-Synuclein Aggregation
Fong LaiGuan Zoey, Mathangi Palanivel, Parasuraman Padmanabhan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 17
Mechanism and therapeutic targets of the involvement of a novel lysosomal proton channel TMEM175 in Parkinson's disease
Tingting feng, Hongcheng zheng, Z. G. Zhang, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102373-102373
Closed Access | Times Cited: 2
Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease
Marcus Pieterman, Scott Adams, Mandar Jog
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 19
Oxidative-Signaling in Neural Stem Cell-Mediated Plasticity: Implications for Neurodegenerative Diseases
Mafalda Ferreira dos Santos, Catarina Roxo, Susana Solá
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1088-1088
Open Access | Times Cited: 15
Iron Concentration Does Not Differ in Blood but Tends to Decrease in Cerebrospinal Fluid in Parkinson’s Disease
Xiaoli Shen, Huazhen Yang, Dongfeng Zhang, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 16
Parkin deficiency accentuates chronic alcohol intake-induced tissue injury and autophagy defects in brain, liver and skeletal muscle
Hu Peng, Xing Qin, Sainan Chen, et al.
Acta Biochimica et Biophysica Sinica (2020) Vol. 52, Iss. 6, pp. 665-674
Closed Access | Times Cited: 14
Deriving Implications for Care Delivery in Parkinson’s Disease by Co-Diagnosing Caregivers as Invisible Patients
Franziska Thieken, Marlena van Munster
Brain Sciences (2021) Vol. 11, Iss. 12, pp. 1629-1629
Open Access | Times Cited: 12
Association between Spirituality and Depression in Elderly People with Parkinson’s Disease in Brazil: Cross-Sectional Study
Samuel Spiegelberg Züge, Julia Grasel, Alessandra Paula Watte, et al.
(2024)
Open Access | Times Cited: 1
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Review of Pre-clinical Studies
Samay Prakash, Wayne G. Carter
(2021)
Open Access | Times Cited: 9
Analysis of Influencing Factors of Apathy in Patients with Parkinson’s Disease
Ruirui Luo, Yumeng Qi, Jiu-Qin He, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1343-1343
Open Access | Times Cited: 6
Erforschung von Erkrankungen in der NAKO Gesundheitsstudie. Die wichtigsten gesundheitlichen Endpunkte und ihre Erfassung
Wolfgang Ahrens, Karin Halina Greiser, Jakob Linseisen, et al.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2020) Vol. 63, Iss. 4, pp. 376-384
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top